3 ms·
And Novo (like many others) is already working on next-generation GLPs that’ll have new patent protection before Ozempic’s ends.
by llamaimperative 2y ago
And Novo (like many others) is already working on next-generation GLPs that’ll have new patent protection before Ozempic’s ends.
- leereeves 2y agoEven so, competition from other GLP-1 drugs and generic semaglutide should make prices and profits lower.
- droopyEyelids 2y agoIf the companies combined can meet demand
- genewitch 2y agoThey seem to be able to offer it at $300 if you pay without insurance. The implication being that they make 50 extra bucks because the insurance company only pays $250 for your $1,000 prescription.